Cleudiomar Inácio Lino

In vitro and in silico studies of antioxidant activity of 2-thiazolylhydrazone derivatives.

T. Kronenberger, R. Labanca, M. Rêgo, 2019, Journal of molecular graphics & modelling.

Anti-Candida albicans Activity of Thiazolylhydrazone Derivatives in Invertebrate and Murine Models

C. Rosa, B. Fuchs, E. Mylonakis, 2018, Journal of fungi.

In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.

B. Fuchs, E. Mylonakis, S. Johann, 2018, Journal of global antimicrobial resistance.

Antivirulence activity and in vivo efficacy of a thiazole derivative against candidiasis.

C. Rosa, J. C. Junqueira, A. D. Valério, 2021, Journal de mycologie medicale.

Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex

B. Fuchs, E. Mylonakis, D. A. Santos, 2017, Antimicrobial Agents and Chemotherapy.

Assessment of anti-diabetic activity of a novel hydrazine-thiazole derivative: in vitro and in vivo method

R. Labanca, E. M. Souza-Fagundes, J. V. Rettore, 2019, Brazilian Journal of Pharmaceutical Sciences.

Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives.

V. Maltarollo, S. Johann, B. Borelli, 2018, European journal of medicinal chemistry.

Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.

C. Rosa, D. A. Santos, S. Johann, 2015, European journal of medicinal chemistry.

Antifungal activity directed toward the Cell wall by 2-cyclohexylidenhydrazo-4-phenyl-thiazole against Candida albicans.

C. Rosa, B. Fuchs, E. Mylonakis, 2018, Infectious disorders drug targets.